Cognito Therapeutics Raises $73M Series B
Summary
Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. New investors Alzheimers Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and WS Investment Company (Wilson Sonsinis venture arm) joined the round. The Series B funding brings the total amount raised since inception to $93 million. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Funding
Amount
$73.0M
Total raised
Date
March 22, 2023
Announcement date
Investors
Video Island
Lead investors
Company
cognitohq.com
Funded company
Classifications
industries
Fintech & Banking
applications
Accounting and Taxes
AskAI Classifications
Labels
Identity Verification Software
KYC Compliance Software
Fraud Detection Software
Linked Companies
Cognito
$1M to $5M